Ürojinekolojik Sorunları Olan Kadınlarda Kanıt Temelli Yaklaşımlar ve Hemşirelik Bakımı
Özet
Ürojinekolojik sorunlar, kadınların yaşam kalitesini olumsuz etkileyen ve genellikle yaşlanma ile ilişkilendirilen sağlık problemleridir. Bu sorunların yönetiminde kanıt temelli yaklaşımlar, hemşirelik bakımının etkinliğini artırmak açısından kritik öneme sahiptir. İlk basamak tedaviler arasında yaşam tarzı değişiklikleri (sıvı alımının düzenlenmesi, obezitenin önlenmesi, sigara ve kafein tüketiminin azaltılması) ve davranışsal-fiziksel terapiler (mesane eğitimi, pelvik taban kas eğitimi, elektriksel stimülasyon) yer alır. Konservatif yöntemler yetersiz kaldığında farmakolojik tedaviler (antikolinerjikler, beta-3 agonistleri, vajinal östrojen) ve gerektiğinde lazer tedavisi uygulanabilmektedir. Daha dirençli olgularda ise invaziv prosedürler (botulinum toksin enjeksiyonu, sakral nöromodülasyon, augmentasyon sistoplasti, kalıcı kateterler) ve cerrahi yöntemler gündeme gelmektedir. Hemşirelik bakımında temel hedef, hastaların semptom yönetimini desteklemek, tedaviye uyumu artırmak ve komplikasyonları en aza indirerek yaşam kalitesini yükseltmektir. Multidisipliner ekip çalışması ve kanıta dayalı klinik rehberlerin entegrasyonu, hasta odaklı bakımın başarısını artırmaktadır. Kanıt temelli hemşirelik bakımı, ürojinekolojik sorunların yönetiminde bu sorunların giderilmesine ve kadınların yaşam kalitesinin artırılmasına katkı sağlayabilir.
Referanslar
ACOG Practice Bulletin No. 155: Urinary Incontinence in Women. Obstetrics and Gynecology. Lippincott Williams & Wilkins; 2015;126(5): e66–e81. doi:10.1097/AOG.0000000000001148
ACOG Practice Bulletin No. 155: Urinary Incontinence in Women. Obstetrics and Gynecology. Committee on Practice Bulletins–Gynecology and the American Urogynecologic Society; 2019;126(5): e66–e81.
Başgöl Ş, Kızılkaya Beji N. Kontinans hemşirelerinin gelişen rollerinin uluslararası düzeyde irdelenmesi. Evaluation of the developing nursing roles at the international level. Florence Nightingale Hemşirelik Dergisi. 2015;23(3): 224-230.
Berre ML, Presse N, Morin M, Larouche M, Campeau L, Hu Y, et al. What do we really know about the role of caffeine on urinary tract symptoms? A scoping review on caffeine consumption and lower urinary tract symptoms in adults. Neurourology and Urodynamics. Wiley; 2020;39(5): 1217-1233. doi:10.1002/nau.24344
Blanchard V, Nyangoh-Timoh K, Fritel X, Fauconnier A, Pizzoferrato AC. Importance of a pelvic floor lifestyle program in women with pelvic floor dysfunctions: A pilot study. Journal of Gynecology Obstetrics and Human Reproduction. Elsevier; 2021;50(4): 102032. doi:10.1016/j.jogoh.2020.102032
Brunt BA, Morris MM. Nursing professional development evidence-based practice. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.
Burgio KL, Goode PS, Richter HE, Markland AD, Johnson TM, Redden DT. Combined behavioral and individualized drug therapy versus individualized drug therapy alone for urge urinary incontinence in women. Journal of Urology. Elsevier; 2010;184(2): 598-603. doi:10.1016/j.juro.2010.04.078
Callan L, Thompson D, Netsch D. Does increasing or decreasing the daily intake of water/fluid by adults affect overactive bladder symptoms? Journal of Wound, Ostomy and Continence Nursing. Wolters Kluwer; 2015;42(6): 614-620. doi:10.1097/WON.0000000000000183
Cameron AP, Chung DE, Dielubanza EJ, Enemchukwu E, Ginsberg DA, Helfand BT, et al. The AUA/SUFU Guideline on the diagnosis and treatment of idiopathic overactive bladder. Journal of Urology. Wolters Kluwer; 2024;212(1): 11-20. doi:10.1097/JU.0000000000003985
D’Ancona CD, Haylen BT, Oelke M, Herschorn S, Abranches-Monteiro L, Arnold EP, Goldman HB, Hamid R, Homma Y, Marcelissen T, Rademakers K, Schizas A, Singla A, Soto I, Tse V, de Wachter S. An International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourology and Urodynamics. Wiley; 2019;38(2): 433-477. doi:10.1002/nau.23897
Dang D, Dearholt SL, Bissett K, Ascenzi J, Whalen M. Johns Hopkins evidence-based practice for nurses and healthcare professionals: Model and guidelines. Sigma Theta Tau International; 2021.
Drake MJ, Doumouchtsis SK, Hashim H, Gammie A. Fundamentals of urodynamic practice, based on International Continence Society good urodynamic practices recommendations. Neurourology and Urodynamics. Wiley; 2018;37(S6): S50-S60. doi:10.1002/nau.23783
Due U, Brostrøm S, Lose G. Lifestyle advice with or without pelvic floor muscle training for pelvic organ prolapse: a randomized controlled trial. International Urogynecology Journal. Springer; 2016;27(4): 555–563. doi:10.1007/s00192-015-2852-0
Dumoulin C, Hay-Smith J. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database of Systematic Reviews. Wiley; 2010;1: CD005654. doi:10.1002/14651858.CD005654.pub2
Dumoulin C, Cacciari LP, Hay-Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database of Systematic Reviews. Wiley; 2018;10: CD005654. doi:10.1002/14651858.CD005654.pub4
Dumoulin C, Hunter KF, Moore K, Bradley CS, Burgio KL, Hagen S, Imamura M, Thakar R, Williams K, Chambers T. Conservative management for female urinary incontinence and pelvic organ prolapse: Review 2013: Summary of the 5th International Consultation on Incontinence. Neurourology and Urodynamics. Wiley; 2016;35(1): 15-20. doi:10.1002/nau.22677
European Association of Urology (EAU). EAU guidelines on non-neurogenic female lower urinary tract symptoms (LUTS) 2024. Arnhem, The Netherlands: European Association of Urology; 2024.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. Going from evidence to recommendations. BMJ. BMJ Publishing Group; 2008;336(7652): 1049-1051. doi:10.1136/bmj.39493.646875.AE
Hadizadeh-Talasaz Z, Khadivzadeh T, Mohajeri T, Sadeghi M. Worldwide prevalence of pelvic organ prolapse: A systematic review and meta-analysis. Iranian Journal of Public Health. Tehran University of Medical Sciences; 2024;53(3): 524–538. doi:10.18502/ijph.v53i3.15134
Harding CK, Lapitan MC, Arlandis S, Bø K, Costantini E, Groen J, Nambiar AK, Omar MI, Peyronnet B, Phé V, Van Der Vaart CH. Non-neurogenic female lower urinary tract symptoms (LUTS): 2024 update. European Urology. Elsevier; 2024;86(1): 1-15. doi:10.1016/j.eururo.2024.02.001
Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. International Urogynecology Journal. Springer; 2010;21(1): 5–26. doi:10.1007/s00192-009-0976-9
Haylen BT, Maher CF, Barber MD, Camargo S, Dandolu V, Digesu A, Goldman HB, Huser M, Milani AL, Moran PA, Schaer GN, Withagen MI. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Neurourology and Urodynamics. Wiley; 2016;35(2): 137–168. doi:10.1002/nau.22922
International Consultation on Incontinence Questionnaire (ICIQ) bladder diary. Available from: https://iciq.net/iciq-bladder-diary
Kalsi V, Apostolidis A, Gonzales G, Elneil S, Dasgupta P, Fowler CJ. Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity. European Urology. Elsevier; 2008;54(1): 181–187. doi:10.1016/j.eururo.2008.02.019
Kobashi KC, Vasavada S, Bloschichak A, et al. Updates to surgical treatment of female stress urinary incontinence (SUI): AUA/SUFU guideline. Journal of Urology. Wolters Kluwer; 2023;209(6): 1091-1098. doi:10.1097/JU.0000000000003271
Kobashi KC, Albo ME, Dmochowski RR, Ginsberg DA, Goldman HB, Gomelsky A, Kraus SR, Sandhu JS, Shepler T, Treadwell JR, Vasavada S, Lemack GE. Surgical treatment of female stress urinary incontinence: AUA/SUFU guideline. Journal of Urology. Elsevier; 2017;198(4): 875-883. doi:10.1016/j.juro.2017.06.061
Lamerton T, Torquati L, Brown WJ. Overweight and obesity as major, modifiable risk factors for urinary incontinence in young to mid-aged women: A systematic review and meta-analysis. Obesity Reviews. Wiley; 2018;19(12): 1735-1745. doi:10.1111/obr.12756
MacDiarmid SA, Peters KM, Shobeiri SA, Wooldridge LS, Rovner ES, Leong FC, Kuo HC. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. Journal of Urology. Elsevier; 2010;183(1): 234-240. doi:10.1016/j.juro.2009.09.026
Mackova K, Van Daele L, Page A, Geraerts I, Krofta L, Deprest J. Laser therapy for urinary incontinence and pelvic organ prolapse: A systematic review. BJOG: An International Journal of Obstetrics & Gynaecology. Wiley; 2020;127(11): 1338-1346. doi:10.1111/1471-0528.16273
Mattiasson A, Masala A, Morton R, Bolodeoku J. Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: Results from a randomized study. BJU International. Wiley; 2010;105(7): 1126-1135. doi:10.1111/j.1464-410X.2009.09176
National Institute for Health and Care Excellence (NICE). Urinary incontinence and pelvic organ prolapse in women: management. NICE guideline [NG123]. London: NICE; 2019. Available from: https://www.nice.org.uk/guidance/ng123
Ogrinc UB, Senčar S, Lenasi H. Novel minimally invasive laser treatment of urinary incontinence in women. Lasers Surg Med. 2015 Nov;47(9):689-97. doi: 10.1002/lsm.22416.
Rizvi RM, Chughtai NG, Kapadia N. Effects of bladder training and pelvic floor muscle training in female patients with overactive bladder syndrome: a randomized controlled trial. Urol Int. 2018;100(4):420-427. doi:10.1159/000488769.
Shendy M, Marinceu D, Roy M, Siddique A, Dakhilallah H. Role of nursing in urogynaecology. In: Chaban V, editor. Nursing - New Insights for Clinical Care. London: IntechOpen; 2023. p. 1-20. doi: 10.5772/intechopen.107275.
Welk B, Richardson K, Panicker JN. The cognitive effect of anticholinergics for patients with overactive bladder. Nat Rev Urol. 2021;18(11):686-700. doi:10.1038/s41585-021-00504-x.
Cody JD, Richardson K, Moehrer B, Hextall A, Glazener CM. (2009). Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database of Systematic Reviews;4:CD001405
Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, Dawes M. Oxford Centre for Evidence-Based Medicine—Levels of Evidence. Oxford Centre for Evidence-Based Medicine; 2009 Mar.
Stewart F, Gameiro O, El Dib R, Kapoor A, Amaro J. Electrical stimulation with non-implanted electrodes for overactive bladder in adults. Cochrane Database Syst Rev. 2016 Dec 9;(12):CD010098.pub4.
Rahn DD, Palmer MH, Mallette MK, Moore KN. Vaginal estrogen for genitourinary syndrome of menopause: A systematic review. Menopause. 2014;21(3):243-249.
Weber AM. Treatment of genitourinary syndrome of menopause. Obstet Gynecol Clin North Am. 2015;42(4):667-681.
